All Cosmos Bio-Tech Holding Corp (4148) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

All Cosmos Bio-Tech Holding Corp (4148) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$267.57 Million) in capital expenditures (NT$5.38 Million). See cash generation quality of All Cosmos Bio-Tech Holding Corp to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

NT$267.57 Million
TWD

Capital Expenditures

NT$5.38 Million
TWD

Data as of

Dec 2025
Most recent filing

All Cosmos Bio-Tech Holding Corp Capital Reinvestment Ratio (2010–2025)

This chart tracks All Cosmos Bio-Tech Holding Corp's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for All Cosmos Bio-Tech Holding Corp (2010–2025)

Year-by-year Capital Reinvestment Ratio for All Cosmos Bio-Tech Holding Corp from 2010 to 2025. For live market cap and broader valuation context, see 4148 stock market capitalisation.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 0.17x NT$251.93 Million NT$42.85 Million ▼ -93.5%
2024 2.63x NT$54.19 Million NT$142.25 Million ▲ +1440.9%
2023 0.17x NT$959.24 Million NT$163.42 Million ▼ -87.7%
2022 1.39x NT$43.84 Million NT$60.86 Million ▲ +3028.3%
2019 0.04x NT$883.56 Million NT$39.21 Million ▼ -74.1%
2017 0.17x NT$176.12 Million NT$30.19 Million ▲ +612.7%
2016 0.02x NT$507.38 Million NT$12.20 Million ▼ -94.3%
2015 0.42x NT$145.77 Million NT$61.10 Million ▼ -56.9%
2014 0.97x NT$97.03 Million NT$94.30 Million ▼ -71.0%
2013 3.35x NT$41.58 Million NT$139.36 Million ▲ +68.3%
2012 1.99x NT$194.85 Million NT$388.07 Million ▲ +79.0%
2011 1.11x NT$138.05 Million NT$153.59 Million ▲ +192.2%
2010 0.38x NT$88.13 Million NT$33.55 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow